These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 29415357)
21. Urine albumin-to-creatinine ratio diurnal variation rate predicts outcomes in idiopathic membranous nephropathy. Chen X; Zhang Y; Yan L; Xie Y; Li S; Zhuang Y; Wang L Clin Exp Nephrol; 2024 May; 28(5):409-420. PubMed ID: 38240880 [TBL] [Abstract][Full Text] [Related]
22. Patient age and the prognosis of idiopathic membranous nephropathy. Yamaguchi M; Ando M; Yamamoto R; Akiyama S; Kato S; Katsuno T; Kosugi T; Sato W; Tsuboi N; Yasuda Y; Mizuno M; Ito Y; Matsuo S; Maruyama S PLoS One; 2014; 9(10):e110376. PubMed ID: 25330372 [TBL] [Abstract][Full Text] [Related]
23. Urinary protein and renal prognosis in idiopathic membranous nephropathy: a multicenter retrospective cohort study in Japan. Yamaguchi M; Ando M; Katsuno T; Tsuboi N; Maruyama S Ren Fail; 2018 Nov; 40(1):435-441. PubMed ID: 30052488 [TBL] [Abstract][Full Text] [Related]
24. Growth Differentiation Factor-15 as a Predictor of Idiopathic Membranous Nephropathy Progression: A Retrospective Study. Ham YR; Song CH; Bae HJ; Jeong JY; Yeo MK; Choi DE; Na KR; Lee KW Dis Markers; 2018; 2018():1463940. PubMed ID: 29682097 [TBL] [Abstract][Full Text] [Related]
25. Clinical and pathological analysis of hepatitis B virus-related membranous nephropathy and idiopathic membranous nephropathy. Li P; Wei RB; Tang L; Wu J; Zhang XG; Chen XM Clin Nephrol; 2012 Dec; 78(6):456-64. PubMed ID: 23164414 [TBL] [Abstract][Full Text] [Related]
27. Different Effects of Tolvaptan in Patients with Idiopathic Membranous Nephropathy with Nephrotic Syndrome. Tanaka A; Nakamura T; Sato E; Ueda Y; Node K Intern Med; 2017; 56(2):191-196. PubMed ID: 28090051 [TBL] [Abstract][Full Text] [Related]
28. Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN). Radice A; Trezzi B; Maggiore U; Pregnolato F; Stellato T; Napodano P; Rolla D; Pesce G; D'Amico M; Santoro D; Londrino F; Ravera F; Ortisi G; Sinico RA Autoimmun Rev; 2016 Feb; 15(2):146-54. PubMed ID: 26527329 [TBL] [Abstract][Full Text] [Related]
29. Long-term outcomes of initial therapy for idiopathic membranous nephropathy. Sato M; Takei T; Moriyama T; Itabashi M; Nitta K Clin Exp Nephrol; 2017 Oct; 21(5):842-851. PubMed ID: 27999961 [TBL] [Abstract][Full Text] [Related]
30. Leflunomide plus oral prednisone in treatment of idiopathic membranous nephropathy: a retrospective clinical study of efficacy and safety. Yang S; Xie L; Xue W; Yin A; Lu W Nephrology (Carlton); 2013 Sep; 18(9):615-22. PubMed ID: 23889815 [TBL] [Abstract][Full Text] [Related]
31. [Anti-phospholipase A2 receptor (anti-PLA2R) antibodies and idiopathic membranous nephropathy: which role in diagnosis and prognosis of this disease?]. Netti GS; Ranieri E G Ital Nefrol; 2014; 31(3):. PubMed ID: 25030016 [TBL] [Abstract][Full Text] [Related]
32. Risk alleles for IgA nephropathy-associated SNPs conferred completely opposite effects to idiopathic membranous nephropathy in Chinese Han. Qin X; Wang C; Lu G; Peng M; Cheng G; Zhu H; Cao Y; Liu J; Li Y; Cai H; Yang F; Liu Y; Chen X; Li L; Wan N; Wen X; Li S; Nie R; Qin D; Li Y; Liu Y Immunol Res; 2017 Oct; 65(5):1059-1064. PubMed ID: 28929317 [TBL] [Abstract][Full Text] [Related]
33. Focal segmental glomerulosclerosis is not a sufficient predictor of renal outcome in patients with membranous nephropathy. Heeringa SF; Branten AJ; Deegens JK; Steenbergen E; Wetzels JF Nephrol Dial Transplant; 2007 Aug; 22(8):2201-7. PubMed ID: 17442739 [TBL] [Abstract][Full Text] [Related]
34. Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy. Svobodova B; Honsova E; Ronco P; Tesar V; Debiec H Nephrol Dial Transplant; 2013 Jul; 28(7):1839-44. PubMed ID: 23223223 [TBL] [Abstract][Full Text] [Related]
35. Serum anti-PLA2R antibody as a diagnostic biomarker of idiopathic membranous nephropathy: The optimal cut-off value for Chinese patients. Liu Y; Li X; Ma C; Wang P; Liu J; Su H; Zhuo H; Kong X; Xu D; Xu D Clin Chim Acta; 2018 Jan; 476():9-14. PubMed ID: 29126817 [TBL] [Abstract][Full Text] [Related]
36. Factors affecting the long-term outcomes of idiopathic membranous nephropathy. Huh H; Lee H; Lee JP; Kim DK; Oh S; Oh YK; Kim YS; Lim CS BMC Nephrol; 2017 Mar; 18(1):104. PubMed ID: 28347297 [TBL] [Abstract][Full Text] [Related]
37. Future embracing: exosomes driving a revolutionary approach to the diagnosis and treatment of idiopathic membranous nephropathy. Wang L; Wang J; Xu A; Wei L; Pei M; Shen T; Xian X; Yang K; Fei L; Pan Y; Yang H; Wang X J Nanobiotechnology; 2024 Aug; 22(1):472. PubMed ID: 39118155 [TBL] [Abstract][Full Text] [Related]
38. The correlation between vitamin D and inflammatory indicators in middle-aged and elderly patients with idiopathic membranous nephropathy. Lu Z; Dai S; Qin L; Nong B; Huang C; Huang Z Cell Mol Biol (Noisy-le-grand); 2022 Sep; 68(10):167-170. PubMed ID: 37114254 [TBL] [Abstract][Full Text] [Related]
39. Low-molecular-weight proteins as prognostic markers in idiopathic membranous nephropathy. van den Brand JA; Hofstra JM; Wetzels JF Clin J Am Soc Nephrol; 2011 Dec; 6(12):2846-53. PubMed ID: 22157712 [TBL] [Abstract][Full Text] [Related]